Gateway Investment Advisers LLC Bristol Myers Squibb CO Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 111,566 shares of BMY stock, worth $6.25 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

111,566

Previous 111,326 0.22%

Holding current value

$6.25 Million

Previous $4.62 Million 24.88%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$39.66 - $51.75 $9,518 - $12,420	240 Added 0.22%	111,566 $5.77 Million
Q2 2024 Jul 12, 2024	BUY	$40.25 - $52.99 $523 - $688	13 Added 0.01%	111,326 $4.62 Million
Q1 2024 Apr 12, 2024	SELL	$47.98 - $54.4 $22 Million - $24.9 Million	-458,478 Reduced 80.46%	111,313 $6.04 Million
Q4 2023 Jan 09, 2024	SELL	$48.48 - $57.85 $2.5 Million - $2.98 Million	-51,529 Reduced 8.29%	569,791 $29.2 Million
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $1.2 Million - $1.34 Million	-20,733 Reduced 3.23%	621,320 $36.1 Million
Q2 2023 Jul 13, 2023	BUY	$63.71 - $70.74 $573,517 - $636,801	9,002 Added 1.42%	642,053 $41.1 Million
Q1 2023 Apr 11, 2023	SELL	$65.71 - $74.53 $169,006 - $191,691	-2,572 Reduced 0.4%	633,051 $43.9 Million
Q4 2022 Jan 13, 2023	SELL	$68.48 - $81.09 $5.79 Million - $6.85 Million	-84,510 Reduced 11.74%	635,623 $0
Q3 2022 Oct 07, 2022	SELL	$0.13 - $76.84 $3,205 - $1.89 Million	-24,656 Reduced 3.31%	720,133 $51.2 Million
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $3.84 Million - $4.23 Million	-52,830 Reduced 6.62%	744,789 $57.3 Million
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $10,205 - $12,237	166 Added 0.02%	797,619 $58.3 Million
Q4 2021 Jan 14, 2022	SELL	$53.63 - $62.52 $1.83 Million - $2.13 Million	-34,072 Reduced 4.1%	797,453 $49.7 Million
Q3 2021 Oct 22, 2021	BUY	$59.17 - $69.31 $49,998 - $58,566	845 Added 0.1%	831,525 $49.2 Million
Q2 2021 Jul 13, 2021	SELL	$61.91 - $67.42 $194,645 - $211,968	-3,144 Reduced 0.38%	830,680 $55.5 Million
Q1 2021 Apr 14, 2021	SELL	$59.34 - $66.74 $994,953 - $1.12 Million	-16,767 Reduced 1.97%	833,824 $52.6 Million
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $105,895 - $119,998	-1,834 Reduced 0.22%	850,591 $52.8 Million
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $131,399 - $145,608	-2,288 Reduced 0.27%	852,425 $51.4 Million
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $10.5 Million - $12.3 Million	-191,366 Reduced 18.29%	854,713 $50.3 Million
Q1 2020 Apr 13, 2020	BUY	$46.4 - $67.43 $1.68 Million - $2.45 Million	36,283 Added 3.59%	1,046,079 $58.3 Million
Q4 2019 Jan 09, 2020	BUY	$49.21 - $64.19 $13.6 Million - $17.8 Million	277,193 Added 37.84%	1,009,796 $64.8 Million
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $2 Million - $2.38 Million	-46,843 Reduced 6.01%	732,603 $37.2 Million
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $2.77 Million - $3.06 Million	-62,014 Reduced 7.37%	779,446 $35.3 Million
Q1 2019 Apr 10, 2019	BUY	$45.12 - $53.8 $746,329 - $889,905	16,541 Added 2.01%	841,460 $40.1 Million
Q4 2018 Jan 14, 2019	BUY	$48.76 - $63.23 $2,779 - $3,604	57 Added 0.01%	824,919 $42.9 Million
Q3 2018 Oct 16, 2018	SELL	$55.19 - $62.25 $298,026 - $336,150	-5,400 Reduced 0.65%	824,862 $51.2 Million
Q2 2018 Jul 11, 2018	SELL	$50.53 - $62.98 $1.86 Million - $2.31 Million	-36,752 Reduced 4.24%	830,262 $45.9 Million
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $2.23 Million - $2.56 Million	-37,159 Reduced 4.11%	867,014 $54.8 Million
Q4 2017 Jan 17, 2018	SELL	$59.94 - $65.35 $3.5 Million - $3.82 Million	-58,412 Reduced 6.07%	904,173 $55.4 Million
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $53.2 Million - $61.4 Million	962,585	962,585 $61.4 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Bristol Myers Squibb CO Transaction History